Antimalondialdehyde Low-Density Lipoprotein Antibody Levels Predict Low-Attenuation Plaque in the SCOT-HEART Trial

JACC Cardiovasc Imaging. 2024 Jan;17(1):98-100. doi: 10.1016/j.jcmg.2023.07.006. Epub 2023 Aug 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic
  • Heart
  • Humans
  • Lipoproteins, LDL
  • Plaque, Atherosclerotic*
  • Predictive Value of Tests

Substances

  • Lipoproteins, LDL